Skip to main content

Value Stock - Dividend - Research Selection

ISIN: , WKN:

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Charles River Laboratories: Price Discovery

2022-11-21
After Charles River’s quick and strong recovery in recent weeks, should investors take profits or hold? Read more to see a full analysis of CRL stock.

Charles River Laboratories to Present at November Investor Conferences

2022-11-14
WILMINGTON, Mass., November 14, 2022--Charles River Laboratories To Present At November Investor Conferences

Bullish Two Hundred Day Moving Average Cross - CRL

2022-11-11
In trading on Friday, shares of Charles River Laboratories International Inc - (CRL) crossed above their 200 day moving average of $242.11, changing hands as high as $248.17 per share. - CRL.

Society for Immunotherapy of Cancer to hold a meeting

2022-11-11
37th Annual Meeting SITC ... ABMD, ADPT, ALKS, AMGN, ASND, BMY, CGEN, CLRB, CRL, INKT, INCY, PHIO, INBX, XNCR, VCYT, TXG, TPST, TMO, TIL, SGEN, REGN, REPL, RHHBY, DNA, CUE, IOVA, IPSC, LH, MRK, MXCT, EXEL, FATE, GMAB

Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022

2022-11-10
WILMINGTON, Mass., November 10, 2022--Charles River announced that its team of neuroscience drug discovery experts will present 23 scientific posters at Neuroscience 2022.

Top 5 3rd Quarter Trades of AR - GuruFocus.com

2022-11-10
GuruFocus Article or News written by insider and the topic is about:

Insider Alert: An Insider Just - GuruFocus.com

2022-11-08
GuruFocus Article or News written by insider and the topic is about:

Charles River Laboratories expanding Memphis CDMO biotech facility

2022-11-07
“This expansion builds on the Memphis site’s demonstrable expertise and commitment to supporting cell and gene therapy clients from early target identification through clinical and commercial-scale manufacturing."

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

2022-11-07
MEMPHIS, Tenn., November 07, 2022--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its cell therapy contract development and manufacturing (CDMO) facility in Memphis, Tenn. The expanded space is suitable for clinical and commercial cell therapy manufacturing, with an additional nine (9) state-of-the-art processing suites, adding to an existing 16 cleanrooms.

Charles River expands CDMO facility in Memphis

2022-11-07
Charles River announced t... CRL